Tang, W., Li, Y., Zhang, L., Zhong, X., Liang, Q., Zheng, Y., . . . Niu, T. Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma. Wiley.
Chicago Style (17th ed.) CitationTang, Wenjiao, et al. Phase I Study of TQB3602, an Oral Proteasome Inhibitor, in Relapsed and Refractory Multiple Myeloma. Wiley.
MLA (9th ed.) CitationTang, Wenjiao, et al. Phase I Study of TQB3602, an Oral Proteasome Inhibitor, in Relapsed and Refractory Multiple Myeloma. Wiley.
Warning: These citations may not always be 100% accurate.